Protalix BioTherapeutics
PLX
#8865
Rank
C$0.11 B
Marketcap
$1.61
Share price
0.00%
Change (1 day)
-12.75%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -C$17.7 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$38.05 Million. In 2023 the company made an earning of C$16.34 Million, an increase over its 2022 earnings that were of -C$16.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$17.7 Million-208.25%
2023 C$16.34 M-199.05%
2022 -C$16.51 Million-40.38%
2021 -C$27.69 Million-732.31%
2020 C$4.37 M-130.53%
2019 -C$14.34 Million189.85%
2018 -C$4.95 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$25.75 Million-32.37%
2015 -C$38.07 Million10.11%
2014 -C$34.58 Million-7.59%
2013 -C$37.42 Million
2011 -C$43.33 Million-19.39%
2010 -C$53.75 Million20.87%
2009 -C$44.47 Million32.26%
2008 -C$33.62 Million-5.46%
2007 -C$35.57 Million
2004 -C$0.24 Million12.35%
2003 -C$0.21 Million-11.1%
2002 -C$0.24 Million-57.03%
2001 -C$0.54 Million1.03%
2000 -C$0.54 Million-53.22%
1999 -C$1.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.14 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.91 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.69 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.15 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel